Clinical trial
Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
NCT00002460 · Cancer Research UK, Other · Unknown status
Key facts
| NCT number | NCT00002460 |
|---|---|
| Title | Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer |
| Official title | Phase III Randomized Study of Adjuvant Therapy With Tamoxifen vs Endocrine Ablation vs Tamoxifen Plus Endocrine Ablation vs No Adjuvant Therapy in Patients Under Age 50 With Operable Breast Cancer |
| Lead sponsor | Cancer Research UK, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure |
| Interventions | goserelin acetate, tamoxifen citrate, ablative endocrine surgery, oophorectomy |
| Start date | Sep 1, 1987 |
| First posted | Jun 9, 2004 |
| Last update posted | Aug 7, 2013 |
| Countries | Belgium, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: